- Home
- IMCR vs PINC Comparison
IMCR vs PINC Comparison
Compare IMCR & PINC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- PINC
- Stock Information
- Founded
- IMCR 2008
- PINC 2013
- Country
- IMCR United Kingdom
- PINC United States
- Employees
- IMCR N/A
- PINC N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- PINC Other Consumer Services
- Sector
- IMCR Health Care
- PINC Consumer Discretionary
- Exchange
- IMCR Nasdaq
- PINC Nasdaq
- Market Cap
- IMCR 1.7B
- PINC 1.9B
- IPO Year
- IMCR 2021
- PINC 2013
- Fundamental
- Price
- IMCR $32.03
- PINC $22.48
- Analyst Decision
- IMCR Buy
- PINC Hold
- Analyst Count
- IMCR 13
- PINC 7
- Target Price
- IMCR $68.73
- PINC $21.42
- AVG Volume (30 Days)
- IMCR 238.6K
- PINC 932.6K
- Earning Date
- IMCR 11-06-2024
- PINC 11-05-2024
- Dividend Yield
- IMCR N/A
- PINC 3.74%
- EPS Growth
- IMCR N/A
- PINC N/A
- EPS
- IMCR N/A
- PINC 1.32
- Revenue
- IMCR $296,312,000.00
- PINC $1,325,477,000.00
- Revenue This Year
- IMCR $28.88
- PINC N/A
- Revenue Next Year
- IMCR $12.61
- PINC $1.59
- P/E Ratio
- IMCR N/A
- PINC $16.74
- Revenue Growth
- IMCR 25.09
- PINC 2.65
- 52 Week Low
- IMCR $29.72
- PINC $17.96
- 52 Week High
- IMCR $76.98
- PINC $23.43
- Technical
- Relative Strength Index (RSI)
- IMCR 56.41
- PINC 63.24
- Support Level
- IMCR $32.65
- PINC $22.81
- Resistance Level
- IMCR $34.78
- PINC $23.33
- Average True Range (ATR)
- IMCR 1.54
- PINC 0.60
- MACD
- IMCR 0.21
- PINC 0.13
- Stochastic Oscillator
- IMCR 74.74
- PINC 73.09
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.
About PINC Premier Inc.
Premier Inc is a Charlotte, North Carolina-based technology-driven healthcare improvement company, uniting an alliance of United States (U.S.) hospitals, health systems, and other providers and organizations to transform healthcare. The company's revenue is all sourced domestically and is reported in two business segments: the supply chain services and the consulting and technology platform of performance services. It generates the majority of its revenue from the supply chain services segment.